Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.30 |
| ▸ | FAAH | O00519 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1787278 | 0.95 | USP2 (0.36) | USP2ALDH1A1CYP3A4MAPTMEN1 | |
| SCHEMBL15408 | 0.87 | THRB (0.34) | USP2ALDH1A1CYP3A4MAPTMEN1 | |
| SCHEMBL8037794 | 0.83 | TSHR (0.52) | USP2ALDH1A1CYP3A4MAPTMEN1 | |
| SCHEMBL6654801 | 0.82 | USP2 (0.53) | USP2ALDH1A1CYP3A4MAPTMEN1 | |
| SCHEMBL8037796 | 0.81 | USP2 (0.40) | USP2ALDH1A1CYP3A4MAPTMEN1 | |
| SCHEMBL25708 | 0.80 | LMNA (0.44) | USP2ALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL8084375 | 0.77 | TSHR (0.53) | USP2ALDH1A1CYP3A4MAPTMEN1 | |
| SCHEMBL15512638 | 0.77 | USP2 (0.37) | USP2ALDH1A1CYP3A4MAPTMEN1 | |
| SCHEMBL7113046 | 0.76 | USP2 (0.39) | USP2ALDH1A1CYP3A4MAPTMEN1 | |
| SCHEMBL11590314 | 0.76 | PTPN1 (0.39) | USP2ALDH1A1CYP3A4MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5470920-A | Impregnating solutions based on at least one reactive thermoplastic poly (imide-amide) oligomer and a coreactant, which can be used especially for the production of preimpregnated intermediate articles | CIBA-GEIGY CORPORATION (US) | 1995-11-28 | — | — | US | disclosed |
| US-5444136-A | Optionally oriented, monomeric and polymeric nonlinearly optically active materials and derivatives thereof | FLAMEL TECHNOLOGIES (FR) | 1995-08-22 | — | — | US | disclosed |
| US-5403907-A | Prepolymers having imide groups | CIBA-GEIGY CORPORATION (US) | 1995-04-04 | — | — | US | disclosed |
| US-5324827-A | Optionally oriented, monomeric and polymeric nonlinearly optically active materials and derivatives thereof | FLAMEL TECHNOLOGIES (FR) | 1994-06-28 | — | — | US | disclosed |
| US-5221723-A | Thermally stable bisimido copolymerizates | CIBA-GEIGY CORPORATION (US) | 1993-06-22 | — | — | US | disclosed |
| US-5198516-A | THERMALLY STABLE BISIMIDO/P-ALLYLANILINE COPOLYMERS | CIBA-GEIGY CORPORATION (US) | 1993-03-30 | — | — | US | disclosed |
| US-5122589-A | Prepregs; filament wound shapes | RHONE-POULENC CHIMIE (FR) | 1992-06-16 | — | — | US | disclosed |
| US-4994536-A | From N,N'-bismaleimide and novolak epoxy acrylate in the presence of imidazole compound; molding materials | RHONE-POULENC CHIMIE (FR) | 1991-02-19 | — | — | US | disclosed |
| US-4973649-A | BISMALEIMIDE, HINDERED AMINE, VINYL OR ALLYL SUBSTITUTED HETEROCYCLE, ACRYLIC ESTER | RHONE-POULENC CHIMIE (FR) | 1990-11-27 | — | — | US | disclosed |
| US-4101493-A | OIL IN WATER POLYMER EMULSION WITH A POLYACRYLIC ESTER | TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) | 1978-07-18 | — | — | US | disclosed |
| US-3935173-A | POLYESTER TYPE OLIGO(METH) ACRYLATE | TOAGOSEI CHEMICAL INDUSTRIAL CO. LTD. (JA) | 1976-01-27 | — | — | US | disclosed |